(The FASEB Journal. 2001;15:243-250.)
© 2001 FASEB
Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function
HUSE KAMENCIC*,
ROBERT W. GRIEBEL
,
ANDREW W. LYON
,
PHYLLIS G. PATERSON§ and
BERNHARD H. J. JUURLINK*1
Departments of
* Anatomy and Cell Biology,
Surgery (Neurosurgery),
Pathology, and
§ College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada
1Correspondence: Department of Anatomy and Cell Biology, 107 Wiggins Road, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada. E-mail: juurlink{at}duke.usask.ca
 |
ABSTRACT
|
|---|
The study aimed to 1) quantify oxidative stress in spinal
cord after crush injury at T6, 2) determine whether the
administration of the procysteine compound
L-2-oxothiazolidine-4-carboxylate (OTC) would up-regulate glutathione
(GSH) synthesis and decrease oxidative stress, and 3)
determine whether decreased oxidative stress results in better tissue
and function retention. We demonstrate that spinal cord compression (5
s with a 50 g aneurysm clip) at T6 in rats results in oxidative
stress that is extensive (significant increases in oxidative stress
seen at C3 and L4) and rapid in onset. Indices of oxidative stress used
were GSH content, protein carbonyl content, and inactivation of
glutathione reductase. Administration of OTC resulted in a marked
decrease in oxidative stress associated with a sparing of white matter
at T6 (16±1.9% retained in OTC-treated animals vs. less than 1% in
saline-treated). Behavioral indices in control, saline-treated, and
OTC-treated animals after 6 wk were respectively: angle board scores
(59°, 32°, and 42°), modified Tarlov score (7, 2.4, and 4.1), and
Basso-Beattie-Bresnahan score (21, 5.3, and 12.9). We conclude that
administration of OTC after spinal cord trauma greatly decreases
oxidative stress and allows tissue preservation, thereby enabling
otherwise paraplegic animals to locomote.Kamencic, H., Griebel,
R. W., Lyon, A. W., Paterson, P. G., Juurlink, B. H. J. Promoting glutathione synthesis after spinal cord trauma
decreases secondary damage and promotes retention of function.
Key Words: central nervous system functional recovery neurotrauma oxidative stress paraplegia
 |
INTRODUCTION
|
|---|
SPINAL CORD TRAUMA often leads to paraplegia and
quadriplegia, imposing a great burden on the individual afflicted as
well as family, friends, and society at large. Although various
experimental treatments have been tried, the only clinically proven
treatment now available for spinal cord trauma is the administration of
methylprednisolone (1
, 2)
. One primary mechanism of action
of methylprednisolone is thought to be the scavenging of lipid peroxyl
radicals, which inhibits the lipid peroxidation cascade (3
, 4)
. Inhibiting oxidative stress should inhibit activation of
nuclear factor kappa B (NF
B) (5)
, thereby inhibiting
activation of proinflammatory gene expression. Indeed,
methylprednisolone does inhibit inflammatory responses after spinal
cord injury (6)
. However, the improvement seen with
methylprednisolone treatment is modest (7)
and may be
associated with adverse side effects (8)
.
Oxidative stress, particularly lipid peroxidation cascades, and
associated inflammation are major secondary mechanisms whereby physical
trauma results in spinal cord injury (9
10
11
12)
. Minimizing
oxidative stress should decrease post-traumatic inflammation since
oxidative stress activates proinflammatory mechanisms (5)
.
The quenching of lipid peroxyl radicals, thought to be a major
mechanism of action by methylprednisolone (3
, 4)
, is only
a small part of the cells total antioxidant defense mechanisms
(12
, 13)
. Since the tripeptide glutathione (GSH) plays
many roles in the minimization of oxidative stress, we reasoned that
promotion of GSH synthesis would be an effective way to decrease
post-traumatic oxidative stress and thereby promote retention of tissue
integrity and function after spinal cord trauma. GSH is involved in the
scavenging of both inorganic and organic peroxides, the sources of
strong oxidants; scavenging of 4-hydroxyalkenals, strong oxidants
derived from lipid peroxides; scavenging of
-oxo-aldehydes, strong
oxidants that are increased under conditions of oxidative stress; and
the regeneration of vitamin E from the vitamin E radical (reviewed in
refs 5
, 13
).
GSH is synthesized in a two-step process, with the first reaction being
the ligation of glutamate with cysteine forming L-
-glutamyl-cysteine
and the second step being the ligation of glycine to
L-
-glutamyl-cysteine, thereby forming GSH. The first step is
rate-limiting, with cysteine being the rate-limiting amino acid
(14)
. Two compounds that have been used to increase
intracellular cysteine are N-acetylcysteine and
L-2-oxothiazolidine-4-carboxylate (OTC). N-acetylcysteine
does not cross the bloodbrain barrier (15)
whereas OTC
does (16)
, and it has been shown to increase brain
cysteine (16)
and GSH (17)
contents.
Furthermore, an in vitro model of spinal cord injury has
demonstrated that OTC but not N-acetylcysteine could
increase neuronal GSH and increase survival (18)
.
The objectives of the experiments described in this article were to
test the hypothesis that increasing spinal cord GSH content by the
administration of OTC after spinal cord injury would be an efficacious
way to reduce oxidative stress and thereby minimize tissue damage and
maximize functional retention. We demonstrate that the data collected
after administration of OTC after spinal cord trauma support our
hypothesis.
 |
MATERIALS AND METHODS
|
|---|
Surgical procedures
Adult male Wistar rats (
320 g) were obtained from Charles
River Canada and housed in a temperature-regulated animal facility,
exposed to a 12 h light/dark cycle and with free access to food
and water. Animals were treated in accordance with the guidelines of
the Canadian Council on Animal Care. Before surgery, the rats received
the analgesic buprenorphine-hydrochloride (Reckitt Colman Ltd.)
subcutaneously (s.c.) at a dose of 0.05 mg/kg and then every 12 h
for the first 72 h after surgery. Anesthesia was performed with
halothane (5% induction and 1% maintenance). Laminectomy was
performed aseptically at T5-T6 to expose the spinal cord. A 5 s
clip compression injury was induced at the T6 spinal cord level using a
modified Kerr-Lougheed aneurysm clip (Walsh Manufacturing, Oakville,
Ontario) with a calibrated force of 50 g as described
previously (19
, 20)
. For delivery of drug or vehicle, a
sterile catheter was placed s.c. running from the dorsum to enter the
peritoneal cavity ventrally; this was done before the laminectomy was
performed. Thirty minutes after spinal cord compression, OTC (Sigma,
St. Louis, Mo.) or saline vehicle was delivered intraperitoneally and
then every 12 h for the next 5 days. The initial dose of OTC was
12 mmol/kg body weight with maintenance doses of 4 mmol/kg body weight.
Animals were closely observed for behavior, eating, and drinking as
well as weight loss for the first 12 h and thereafter at a minimum
of three times daily. Manual bladder expressions were performed three
times daily.
Measurements of oxidative stress
A total of 54 animals was used to determine the onset of
oxidative stress after spinal cord injury. We used GSH level, protein
carbonyl content and glutathione reductase activity as markers of
oxidative stress with spinal cord tissue isolated at 1 h, 3 h, 6 h, 24 h, and 48 h after injury. Rats were
transcardially perfused with cold saline, vertebral columns were cooled
with liquid nitrogen, and the after spinal cord segments were isolated:
C3, T3, T5, T6, T7, T9, and L4. Spinal cord segments were frozen in
liquid nitrogen and stored at -80°C until analyzed.
GSH was measured using 5,5'-dithio-bis(2-nitrobenzoic)
acid-derivatization [DTNB], followed by high-performance liquid
chromatography (HPLC) and UV detection (21)
. Briefly,
tissues were homogenized in 5% sulfosalicylic acid containing 0.2 mM
EDTA and sonicated (3x5 s, with intermittent cooling). The homogenates
were centrifuged at 10,000 g for 15 min and supernatants
were collected, derivatized, and analyzed using the Shimadzu
reversed-phase HPLC with ultraviolet detection. We used a final
concentration of 3500 nmol DTNB per reaction for a total volume of 1
ml. Data were collected digitally with Shimadzu Ezchrom Version 3.2
chromatography software. GSH content in rat spinal segments was
expressed in mol/g wet weight.
Protein carbonyl content was determined spectrophotometrically using
2,4-dinitrophenylhydrazine (DNPH) to trap carbonyls with the adduct
formed measured at 360 nm (22)
. Results are expressed as
pmol of DNPH incorporated per mg of protein calculated using a molar
absorption coefficient of 22,000 M-1
cm-1 for aliphatic hydrazones.
Glutathione reductase was calculated by measuring the disappearance of
NADPH (Sigma) in the presence of oxidized-glutathione based on the
procedure described by Eklow et al. (23)
, as we have done
previously (24)
.
Measurement of functional recovery
For behavioral studies, 39 animals were randomly assigned to one
of three groups: 1) animals that had no surgery (5 animals);
2) animals with surgery and spinal cord compression that
received OTC (17 animals); and 3) animals that received
surgery and spinal cord compression that received the saline vehicle
only (17 animals). One of the saline-treated and four of the
OTC-treated animals were killed because of bladder complications. One
saline- and one OTC-treated animal were each killed because of
complications arising from the surgery.
Three behavioral tests were used: the angle board method
(25)
, a modified Tarlov score (26)
, and the
Basso-Beattie-Bresnahan (BBB) open field locomotor rating scale
(27)
. The inclined plane is a behavioral task that
assesses the animals ability to maintain its position on a rubber
corrugated board; this board was raised at 5° increments. The maximum
angle at which an animal can support its weight for 5 s is the
capacity angle.
A semiquantitative assessment of hind limb function during open field
walking was performed using the Tarlov scale as modified by Tariq and
colleagues (26)
. Spontaneous activity of hind limb was
scored as follows: 0 = total paraplegia of hind limbs; 1 = no
spontaneous movements but responds to hind limb pinch; 2 =
spontaneous movement; 3 = able to support weight but unable to
walk; 4 = walks with gross deficit; 5 = walks with mild
deficit on broad flat surface, 6 = able to walk on broad flat
surface and support weight on a 1.8 cm wide ledge; 7 = walks on a
ledge.
Procedures for the open field training and testing of the BBB score as
described in Basso et al. (27)
were acquired only part way
through the study; hence, BBB testing was done on only 11
saline-treated and 7 OTC-treated animals. The scale has 22 levels that
range from 0 (= total paralysis) to 21 (= normal locomotion). Briefly,
rats were gentled and adapted to the open field during the fifth week
postsurgery and animals were tested at 6 wk The final open field tests
were videotaped for some rats.
Spinal cord histomorphometry
After 6 wk of behavioral evaluation, the spinal cords were fixed
by transcardial perfusion with 0.03 M phosphate-buffered saline (pH
7.4) containing 1% sodium nitrite in rats anesthetized with halothane,
followed by perfusion (100 ml/100 g) with either 4% formaldehyde
(freshly prepared from paraformaldehyde) or FAM solution (formaldehyde,
acetic acid, and methanol in 1:1:8 ratio) and left in the same fixative
for 5 days. Spinal cord segments were isolated from each animal,
embedded in paraffin, cut into 15 µm thick sections, stained for
myelin with Luxol fast blue, and counterstained with cresyl violet.
Spinal cord tissue staining deep blue was interpreted as being intact
white matter. Area of white matter was quantified using Northern
Eclipse software and expressed in pixels.
Chemicals
All chemicals used for the analytical procedures were obtained
from Sigma.
Statistics
Data are expressed as means ± SE. Where
SEMs are not visible, they are smaller than the symbols.
Statistical analyses were performed with the program InStat.
 |
RESULTS
|
|---|
Spinal cord trauma resulted in a rapid and extensive onset of
oxidative stress as determined by GSH measurements (Fig. 1
). At T6, the site of injury, GSH content was reduced to less than half
of the normal within 1 h, with immediately adjacent segments
having almost as large a drop in GSH. Over the next 48 h there
were further decreases in spinal cord GSH, with sites as distant as C3
and L4 experiencing significant decreases. Laminectomy without spinal
cord crush caused a small (10%) drop in GSH at T6 but had no effect on
other levels of the spinal cord (results not presented). The large
decrease in GSH at the site of injury and adjacent segments was
correlated with a significant decrease in activity of glutathione
reductase 24 h post-trauma in spinal cord segments T3 to T9
(Fig. 2
). Protein carbonyls were significantly increased in spinal cord levels
T3-T9 examined 24 h after injury; the site of injury and
immediately adjacent segments experienced the greatest increase in
protein carbonyls (Fig. 3
).

View larger version (35K):
[in this window]
[in a new window]
|
Figure 1. Spinal cord GSH levels in control nontraumatized animals and in
traumatized animals at different times post-trauma. Data are means ± SE (n=3). Within 1 h GSH has dropped
significantly at T5 (P<0.001), T6
(P<0.001), T7 (P<0.001), and T9
(P<0.05). By 48 h GSH has significantly dropped at
C3 (P<0.01), T3 (P<0.05), T9
(P<0.001), and L4 (P<0.001). One-factor
ANOVA with post hoc Bonferrroni test, with time as the
dependent variable.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Figure 2. Spinal cord glutathione reductase activity under control conditions and
24 h after spinal cord injury with either saline vehicle or OTC
treatment. Data are means ± SE (n=3).
Spinal cord injury with saline vehicle treatment caused a significant
decrease in glutathione reductase activity at T3
(P<0.05), T5 (P<0.01), T6
(P<0.001), T7 (P<0.001), and T9
(P<0.001). Treatment with OTC significantly inhibited
the decrease in glutathione reductase activity at T5
(P<0.05), T6 (P<0.01), T7
(P<0.01), and T9 (P<0.01). One-tailed
Students t test.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Figure 3. Spinal cord protein carbonyl content under control and 24 h
post-trauma in saline- and OTC-treated animals. Data are means ±
SE (n=3). Using a one-tailed Students
t test, spinal cord trauma caused a significant increase
in protein carbonyl at T3 (P<0.01), T5
(P<0.001), T6 (P<0.001), T7
(P<0.001), T9 (P<0.001), and L4
(P<0.001), while addition of OTC significantly
decreased protein carbonyl formation at T5 (P<0.05), T6
(P<0.01), T7 (P<0.01), and T9
(P<0.05).
|
|
Animals weighed 328.3 ± 4.2 g prior to surgery. The weight
of saline-treated animals 6 wk after surgery increased to
403.9 ± 9.5 g while the weight gain of OTC-treated animals
was significantly greater (P=0.0337, two-tailed
Students t test) at 434.3 ± 9.3 g.
Administration of OTC after injury increased spinal cord GSH
(Fig. 4
) and resulted in higher glutathione reductase activity (Fig. 2)
and
decreased protein carbonyl content (Fig. 3)
compared to animals given
the saline vehicle.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 4. Spinal cord GSH content 26 h after injury and 2 h after OTC
administration comparing saline vehicle treatment with OTC treatment.
Data are means ± SE (n=3). A Wilcoxon
spinal cord segment paired nonparametric two-tailed test indicated that
spinal cord GSH levels were significantly different
(P=0.0033) in the OTC-treated vs. the saline-treated
group of rats.
|
|
Six weeks after spinal cord crush in saline-treated animals, much of
the T6 spinal cord was occupied by a large cystic cavity with no gray
matter evident and less than 1% of white matter remaining (Fig. 5
). Administration of OTC did not result in gray matter sparing at T6,
but a peripheral rim of white matter was observed at T6 in all spinal
cords examined from animals that were administered OTC (Fig. 5)
. The
amount of white matter retained varied from 10.5 to 26% of the control
value (Fig. 6
).

View larger version (140K):
[in this window]
[in a new window]
|
Figure 5. Photomicrographs of T6 spinal cords stained with cresyl violet and
Luxol fast blue. Dorsal is at the top. A) Control spinal
cord with dorsal and ventral roots evident below dura mater. The
remaining spinal cords were fixed 6 wk after spinal cord trauma.
B) Typical example of a spinal cord from a
saline-treated animal with a BBB score of 4. Much of T6 spinal cord is
cystic. Although myelinated dorsal and ventral roots are evident, there
is little spinal cord Luxol fast blue-positive central myelin.
C) Spinal cord from an OTC-treated animal with a BBB
score of 11. Although cystic, a thin rim of myelinated axons is evident
in the spinal cord. Arrow indicates a region with substantial amount of
white matter retained. D) Spinal cord from an
OTC-treated animal with a BBB score of 14. A larger proportion of
myelinated axons is retained in this spinal cord.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Figure 6. Graph depicting area of white matter in pixels at mid-T6 spinal cord
segment in control as well as saline-treated and OTC-treated animals
that underwent spinal cord crush at T6. Data represent means ±
SE (n=3). OTC-treated animals have
significantly more Luxol fast blue-stained material than saline-treated
animals (P<0.05, two-tailed Welchs t
test).
|
|
Spinal cord trauma caused a decrease in angle board capacity angle from
59° to 28° (Fig. 7
); during the 6 wk recovery in saline-treated animals this increased to
32° whereas in OTC-treated animals this increased to 42° (Fig. 7)
.
Trauma decreased the Tarlov score from 7 to 1 (Fig. 8A
). Over the next 6 wk, saline-treated animals increased
their Tarlov score to 2.4 whereas OTC-treated animals increased to 4.1.
BBB scores for 6 wk recovery are given in Fig. 8B
. The
behavior of 5 animals that underwent laminectomy without spinal cord
crush was examined after 1 wk. The Tarlov score was 6.93 ± 0.06
in these animals, which was not significantly different from the 7.0
before the laminectomy, and capacity angle was 57.2 ± 1.0, which
was not significantly different from the 58.2 ± 0.3 prior to the
laminectomy.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 7. Angle board scores (means±SE) of animals prior to and
after spinal cord crush in animals treated with saline vehicle
(n=15) and OTC (n=12). Using ANOVA and
post hoc Bonferroni test, the capacity angles between
saline treated and OTC treated are significantly different from 1 wk
onward (P<0.01).
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Figure 8. Behavioral scores of animals before and after spinal cord injury.
A) Tarlov scores between saline (n=15)
and OTC-treated (n=12) animals are significantly
different from 1 wk onward (P<0.001: one-way ANOVA with
a post hoc Bonferroni test). B) BBB
scores of the same animals at 6 wk after injury. OTC-treated animals
(n=7) have a significantly better BBB score than
saline-treated animals (n=11) (P<0.0001,
two-tailed Students t test).
|
|
 |
DISCUSSION
|
|---|
Model
The model of spinal cord trauma in this study, first
described by Rivlin and Tator (19)
, was chosen because it
has been demonstrated to give consistent results (20)
. The
damage caused by the 50 g force aneurysm clip is severe and
resulted in permanent paraplegia with little recovery of hind limb
function, as has been described previously (20)
. This is
in keeping with the histological picture showing cystic T6 spinal cord
segment with almost no white matter remaining. Trauma caused loss of
bladder control, but after 3 wk both saline-treated and OTC-treated
animals regained bladder control. More OTC-treated animals (four
animals) were lost due to bladder problems than saline-treated animals
(one animal). This was correlated with regain of skeletal muscle
function, which enabled animals to actively resist bladder expression;
hence, we do not believe this was a direct adverse effect of OTC, but
yet another indicator of better recovery in the OTC-treated animals.
Oxidative stress
Three criteria indicated that spinal cord trauma resulted in
severe oxidative stress being experienced by the tissue directly
traumatized as well as segments immediately adjacent to the traumatized
T6 segment. These were decreases in tissue GSH, decreases in tissue
glutathione reductase activity, and increases in protein carbonyl
content. These criteria were chosen for the following reasons:
1) oxidative stress consumes GSH either by oxidation or
through formation of adducts with electrophilic compounds (5
, 13)
; 2) protein carbonyls are formed after exposure
to a variety of oxidants (28
29
30)
and thus serves as a
good overall index of oxidative stress experienced by a tissue; and
3) glutathione reductase is enzymatically inactivated by a
number of oxidants (31
32
33)
and, thus, affords an
effective functional index of tissue oxidative stress.
Within 1 h there were significant decreases in GSH in spinal
segments T5 to T9, with the greatest decrease seen at the site of
injury and immediately adjacent segments. Over the next 2 days, and
particularly between 24 and 48 h, GSH levels were significantly
decreased not only from T5-T9, but also throughout the spinal cord from
spinal segments C3 to L4. This may be due to the oxidative stress that
accompanies the prominent inflammatory changes seen after spinal cord
trauma (34
35
36
37)
. Other laboratories have shown that within
less than 1 h of spinal cord trauma there is activation of NF
B,
which persists for at least 72 h (34)
, and by 24 h there is massive neutrophil infiltration and the presence of large
numbers of activated microglia/macrophages at the site of injury as
well as adjacent sites (35)
. Our preliminary observations
(not presented) also demonstrate marked inflammatory changes at 24 h postinjury. The role of these inflammatory leukocytes in secondary
injury is indicated by the significantly increased retention of
function after spinal cord trauma if neutrophils (36)
or
macrophages (37)
are depleted. That oxidative stress is
also severe at the site of injury and immediately adjacent segments is
supported by the significant decrease in activity of glutathione
reductase in the spinal cord segments T3 to T9 and by the increase in
protein carbonyl content 24 h after spinal cord crush.
The GSH that disappeared from the tissue could not be recovered as
oxidized glutathione (GSSG). Preliminary experiments using sodium
borohydride to reduce glutathiyl-protein adducts from injured spinal
cord suggest that GSSG produced formed glutathiyl-protein adducts. This
agrees with other studies demonstrating that glutathiyl-protein adducts
are formed during oxidative stress (38
39
40)
. Such adducts
cannot be reduced by glutathione reductase; hence, de novo
synthesis of GSH becomes critical in the tissues antioxidant
mechanisms. De novo synthesis of GSH is what administration
of OTC facilitates. Work in other laboratories has demonstrated that
tissue cysteine levels peak 4 h after administration of OTC
(16)
. This suggests that GSH levels should peak
4 h
after administration of OTC. In an environment where there is oxidative
stress, GSH is being consumed due to antioxidant activities; therefore,
rises in GSH after administration of OTC would be expected to be
limited. Nevertheless, we found measurable increases in spinal cord GSH
in OTC-treated animals relative to saline-treated controls; these GSH
increases were associated with an overall decrease in oxidative stress
experienced by the spinal cords as determined by measuring glutathione
reductase activities and protein carbonyl contents. We conclude that
administration of OTC significantly reduced oxidative stress after
spinal cord trauma.
Tissue and functional sparing
The decrease in oxidative stress after OTC administration was
associated with sparing of white matter at T6 as indicated by Luxol
fast blue staining. Luxol fast blue is a classical myelin stain. Six
weeks after injury the stained myelin will be associated with intact
axons. Hence, Luxol fast blue staining is an indirect measure of intact
axons, with cross-sectional area of staining being correlated with
total number of intact axons. The validity of measuring Luxol fast
blue-stained spinal cord as a measure of intact white matter is
indicated by the positive correlation between this measure and the
functional scores. However, additional studies are required that
involve counts of retrogradely and anterogradely labeled neurons
similar to that performed by Fehlings and Tator (41)
. In
the animals measured, the average amount of white matter spared was
between 10.5 and 26% in comparison to less than 1% in the
saline-treated animals. Although this is a modest amount, the crush
insult was severe. No gray matter was retained at T6; this is similar
to the earlier findings of Khan and Griebel (20)
. Sparing
of white matter allowed significant functional recovery with animals
attaining BBB scores ranging from 11 to 14 in comparison to a score of
5.3 with saline-treated animals. Previous research by Fehlings and
Tator has demonstrated that as little as 12% of axons retained after
injury allows considerable locomotory function as determined by
measuring inclined plane capacity angles (41)
.
Significance
There are several possible approaches for therapeutic intervention
after spinal cord injury. One approach is to try to repair the damage,
for example, by promoting axon regeneration (42)
or
through introduction of embryonic stem cells that differentiate and
possibly re-establish some of the disrupted circuitry
(43)
; these are technically challenging approaches.
A second approach is to minimize secondary mechanisms of tissue damage
after spinal cord injury. Prevention of damage is a much more
efficacious treatment of spinal cord injury than to attempt repair once
damage has occurred. Other than the very modest sparing effect of
methylprednisolone, so far there is no effective way of diminishing
secondary damage after spinal cord injury. The findings with
methylprednisolone indicate that minimizing oxidative stress can have
beneficial therapeutic consequences. Since there are many pathways that
cause oxidative stress and methylprednisolone acts on only a few of
these pathways, any intervention that can act on more than one pathway
has the potential to be highly effective in minimizing oxidative stress
after a perturbation. As outlined at the beginning of this article, GSH
is involved with many pathways that minimize oxidative stress. The
promotion of de novo GSH synthesis is especially critical
since the glutathione that becomes oxidized after spinal cord trauma
forms glutathiyl-protein adducts and, thus, is no longer available to
be reduced back to GSH. In principle, therefore promoting GSH synthesis
should be an effective way to minimize oxidative stress and thus
minimize secondary damage. Indeed, this is what we find.
In summary, we demonstrate that administration of the cysteine prodrug
L-2-oxothiazolidine-4-carboxylate, which has shown few adverse effects
in numerous small human clinical trials (44
45
46)
, can
effectively minimize oxidative stress and tissue damage after spinal
cord trauma, resulting in significant retention of function. Our data
suggest that promoting GSH synthesis may be an effective therapeutic
approach for treating spinal cord injury in humans. In the research
described in this paper we have examined only one dosing regimen, based
on the data presented in Anderson and Meister (16)
and
Mesina et al. (17)
, and a therapeutic intervention
starting at only one time point after injury. We have not yet examined
for any interactions with methylprednisolone, the only approved
intervention after spinal cord injury in humans. It is clear that
before clinical trials can begin, a dose response study must be
performed, the therapeutic window identified, and whether there are
synergistic or antagonistic interactions with methylprednisolone must
be determined. Some of these studies are under way, and preliminary
data indicate that significant therapeutic effects are seen with doses
as low as 1 mmol/kg body weight.
 |
ACKNOWLEDGMENTS
|
|---|
The ideas that led to this research project arose from research
that was funded by the Medical Research Council of Canada (# MT 13467
to B.H.J.J.). This specific project was funded by the Neurotrauma
Initiative, Saskatchewan. H.K. holds a Health Services Utilization and
Research Commission (Saskatchewan) Post-Doctoral Fellowship. We thank
Angela Damant, Arlene Drimmie, and Michelle Moroz for their excellent
technical assistance. Finally, we wish to thank Drs. Brenda Cross and
Ernie Olfert for offering advice on the postsurgical maintenance of the
animals.
Received for publication April 11, 2000.
Revision received July 7, 2000.
 |
REFERENCES
|
|---|
-
Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., Fehlings, M., Herr, D. L., Hitchon, P. W., Marshall, L. F., Nockels, R. P., Pascale, V., Perot, P. L., Jr, Piepmeier, J., Sonntag, V. K., Wagner, F., Wilberger, J. E., Winn, H. R., Young, W. (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. J. Am. Med. Assoc. 277,1597-1604[Abstract/Free Full Text]
-
Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., Fehlings, M. G., Herr, D. L., Hitchon, P. W., Marshall, L. F., Nockels, R. P., Pascale, V., Perot, P. L., Jr, Piepmeier, J., Sonntag, V. K., Wagner, F., Wilberger, J. E., Winn, H. R., Young, W. (1998) Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89,699-706[Medline]
-
Hall, E. D. (1992) The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76,13-22[Medline]
-
Koc, R. K., Akdemir, H., Karakucuk, E. I., Oktem, I. S., Menku, A. (1999) Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37,29-32[Medline]
-
Christman, J. W., Blackwell, T. S., Juurlink, B. H. J. (2000) Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol 10,153-162[Medline]
-
Bartholdi, D., Schwab, M. E. (1995) Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672,177-186[Medline]
-
Nesathurai, S. (1998) Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J. Trauma 45,1088-1093[Medline]
-
Galandiuk, S., Raque, G., Appel, S., Polk, H. C., Jr (1993) The two-edged sword of large-dose steroids for spinal cord trauma. Ann. Surg. 218,419-425[Medline]
-
Brown, S. A., Hall, E. D. (1992) Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries. J. Am. Vet. Med. Assoc. 200,1849-1859[Medline]
-
Anderson, D. K., Hall, E. D. (1993) Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22,987-992[Medline]
-
Springer, J. E., Azbill, R. D., Mark, R. J., Begley, J. G., Waeg, G., Mattson, M. P. (1997) 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68,2469-2476[Medline]
-
Juurlink, B. H. J., Paterson, P. G. (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J. Spinal Cord Med. 21,309-334[Medline]
-
Juurlink, B. H. J. (1999) Management of oxidative stress in the CNS: the many roles of glutathione. Neurotox. Res. 1,119-140[Medline]
-
Meister, A. (1989) Metabolism and function of glutathione. In
Glutathione. Chemical, Biochemical, and Medical Aspects
(Dolphin, D., Avramovic, O., and Poulson, R., eds) Vol. A, pp.
367474, John Wiley & Sons, New York
-
McLellan, L. I., Lewis, A. D., Hall, D. J., Ansell, J. D., Wolf, C. R. (1995) Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations. Carcinogenesis 16,2099-2106[Abstract/Free Full Text]
-
Anderson, M. E., Meister, A. (1989) Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate. FASEB J 3,1632-1636[Abstract]
-
Mesina, J. E., Page, R. H., Hetzel, F. W., Chopp, M. (1989) Administration of L-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brain. Brain Res 478,181-183[Medline]
-
Lucas, J. H., Wheeler, D. G., Emery, D. G., Mallery, S. R. (1998) The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons. J. Neuropathol. Exp. Neurol. 57,937-954[Medline]
-
Rivlin, A. S., Tator, C. H. (1979) Effect of duration of acute spinal cord compression in a new acute injury model in the rat. Surg. Neurol. 9,39-43
-
Khan, M., Griebel, R. (1983) Acute spinal cord injury in the rat: comparison of three experimental techniques. Can. J. Neurol. Sci. 10,161-165[Medline]
-
Komuro, C., Ono, K., Shibamoto, Y., Nishidai, T., Takahashi, M., Abe, M. (1985) Rapid and simple method for quantitative determination of non-protein sulphydryls in mouse liver by reversed-phase high-performance chromatography. J. Chromatogr. 338,209-212[Medline]
-
Levine, R. L., Garland, D., Olivier, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B., Shaltiel, S., Stadtman, E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186,464-478[Medline]
-
Eklow, L., Moldeus, P., Orrenius, S. (1984) Oxidation of glutathione during hydroperoxide metabolism. Eur. J. Biochem. 138,459-463[Medline]
-
Juurlink, B. H. J., Thorburne, S. K., Hertz, L. (1998) Peroxide scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22,371-378[Medline]
-
Rivlin, A. S., Tator, C. H. (1977) Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47,577-581[Medline]
-
Tariq, M., Morais, C., Kishore, P. N., Biary, N., Al Deeb, S., Al Moutaery, K. (1998) Neurological recovery in diabetic rats following spinal cord injury. J. Neurotrauma 15,239-251[Medline]
-
Basso, D. M., Beattie, M. S., Breshnahan, J. C. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12,1-21[Medline]
-
Burcham, P. C., Kuhan, Y. T. (1996) Introduction of carbonyl groups into proteins by the lipid peroxidation product, malondialdehyde. Biochem. Biophys. Res. Commun. 220,996-1001[Medline]
-
Blakeman, D. P., Ryan, T. P., Jolly, R. A., Petry, T. W. (1998) Protein oxidation: examination of potential lipid-independent mechanisms for protein carbonyl formation. J. Biochem. Mol. Toxicol. 12,185-190[Medline]
-
Miyata, T., Inagi, R., Asahi, K., Yamada, Y., Horie, K., Sakai, H., Uchida, K., Kurokawa, K. (1998) Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett 437,24-28[Medline]
-
Blakytny, R., Harding, J. J. (1992) Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem. J. 288,303-307
-
Tabatabaie, T., Floyd, R. A. (1994) Susceptibility of glutathione peroxidase and glutathione reductase to oxidative damage and the protective effect of spin trapping agents. Arch. Biochem. Biophys. 314,112-119[Medline]
-
Barker, J. E., Heales, S. J., Cassidy, A., Bolanos, J. P., Land, J. M., Clark, J. B. (1996) Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res 716,118-122[Medline]
-
Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., Yezierski, R. P. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18,3251-3260[Abstract/Free Full Text]
-
Carlson, S. L., Parrish, M. E., Springer, J. E., Doty, K., Dossett, L. (1998) Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151,77-88[Medline]
-
Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Kushimoto, S., Johno, M., Naruo, M., Okabe, H., Takatsuki, K. (1997) Role of neutrophils in spinal cord injury in the rat. Neuroscience 79,1177-1182[Medline]
-
Popovich, P. G., Guan, Z., Wei, P., Huitinga, I., van Rooijen, N., Stokes, B. T. (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158,351-365[Medline]
-
Bellomo, G., Mirabelli, F., DiMonte, D., Richelmi, P., Thor, H., Orrenius, C., Orrenius, S. (1987) Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem. Pharmacol. 36,1313-1320[Medline]
-
Schuppe, I., Moldéus, P., Cotgreave, I. A. (1992) Protein-specific S-thiolation in human endothelial cells during oxidative stress. Biochem. Pharmacol. 44,1757-1764[Medline]
-
Shivakumar, B. R., Kolluri, S. V., Ravindranath, V. (1995) Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. J. Pharmacol. Exp. Ther. 274,1167-1173[Abstract/Free Full Text]
-
Fehlings, M. G., Tator, C. H. (1995) The relationship among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132,220-228[Medline]
-
Huang, D. W., McKerracher, L., Braun, P. E., David, S. (1999) A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24,639-647[Medline]
-
McDonald, J. W., Liu, X. Z., Qu, Y., Liu, S., Mickey, S. K., Turetsky, D., Gottlieb, D. I., Choi, D. W. (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med 5,1410-1412[Medline]
-
Kalayjian, R. C., Skowron, G., Emgushov, R.-T., Chance, M., Spell, S. A., Borum, P. R., Webb, L. S., Mayer, K. H., Jackson, L. B., Yen-Lieberman, B., Story, K. O., Rowe, W. B., Thompson, K., Goldberg, D., Trimbo, S., Lederman, M. M. (1994) A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (Procysteine) in asymptomatic HIV-infected subjects. J. Acquir. Immune Defic. Syndr. 7,369-374
-
Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., Wright, P. E. (1997) A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The antioxidant in ARDS Study Group. Chest 112,164-172[Abstract/Free Full Text]
-
Vita, J. A., Frei, B., Holbrook, M., Gokce, N., Leaf, C., Keaney, J. F. (1998) L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest. 101,1408-1414[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Golding, S. T. R. MacDonald, B. H. J. Juurlink, and B. W. C. Rosser
The effect of glutamine on locomotor performance and skeletal muscle myosins following spinal cord injury in rats
J Appl Physiol,
October 1, 2006;
101(4):
1045 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sun, A. Y. Shih, H. C. Johannssen, H. Erb, P. Li, and T. H. Murphy
Two-photon Imaging of Glutathione Levels in Intact Brain Indicates Enhanced Redox Buffering in Developing Neurons and Cells at the Cerebrospinal Fluid and Blood-Brain Interface
J. Biol. Chem.,
June 23, 2006;
281(25):
17420 - 17431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wu, M. H. Noyan Ashraf, M. Facci, R. Wang, P. G. Paterson, A. Ferrie, and B. H. J. Juurlink
Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system
PNAS,
May 4, 2004;
101(18):
7094 - 7099.
[Abstract]
[Full Text]
[PDF]
|
 |
|